Thompson Davis & Co., Inc. Durect Corp Transaction History

Thompson Davis & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $4,794 - $6,978	-5,327 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.06 - $1.69 $5,646 - $9,002	5,327 New	5,327 $6,000
Q2 2018 Aug 03, 2018	SELL	$1.56 - $2.51 $16,907 - $27,203	-10,838 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$0.91 - $2.24 $9,862 - $24,277	10,838 New	10,838 $23,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.